why choose us

First received: January 06, 2023

Clinical Trial: Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Advanced Urothelial Carcinoma

Study Type: INTERVENTIONAL


Official Title: A Phase II Trial With Copanlisib Plus Avelumab as a Maintenance Therapy for Metastatic Bladder Cancer After Platinum-based Chemotherapy

Brief Summary: Patients with metastatic bladder cancer are usually treated with chemotherapy.If their cancers do not progress after chemotherapy, they can be enrolled into this study and receive a standard-of-care immunotherapy medication named avelumab plus a study drug named copanlisib.

Read more